b'Scientific Session Abstracts SATURDAY APRIL 20, 2024 Table 2. Univariate and multivariate association of the CA flow status with outcome variablesUnivariate MultivariateOR p-value aOR p-value Overall 30-day mortality 2.04 [1.17; 3.54] 0.011 2.70 [1.12; 6.46] 0.026Disease/treatment-related1.95 [1.02; 3.70] 0.042 3.21 [1.02; 10.13] 0.047mortalityPostoperative SCI 1.12 [0.55; 2.32] 0.751 0.97 [0.43; 2.19] 0.944Postoperative intestinal1.91[0.59; 6.08] 0.274 1.03 [0.76; 10.68] 0.122ischemiaPostoperative intestinal3.82 [0.66; ischemia requiring3.57 [0.79; 16.09] 0.098 22.29] 0.136interventionMACE 1.59 [1.01; 2.49] 0.043 1.37 [0.83; 2.27] 0.218Postoperative Complications 1.42 [1.00; 2.00] 0.049 1.19 [0.79; 1.79] 0.417Completion endoleak 2.15 [1.22; 3.79] 0.008 1.50 [0.79; 2.83] 0.215Completion Type 1b EL 2.26 [0.96; 5.31] 0.061 1.63 [0.59; 4.50] 0.348Completion Type 2 EL 3.62 [1.24; 10.56] 0.018 4.77 [1.11; 20.43] 0.035Aortic reinterventions 1.22 [0.59; 2.54] 0.591 1.16 [0.51; 2.63] 0.731ICU Stay, days0.92 [-0.04; 1.87] 0.060 0.56 [-0.28; 1.40] 0.193Total length of stay, days3.32 [-3.76; 10.39] 0.358 4.32 [-2.93; 11.57] 0.242OR, odds ratio; aOR, adjusted odds ration; MACE, major adverse cardiovascular events; SCI, spinal cord ischemia, EL, endoleak ;, slope coefficient of the univariable (B1) and adjusted slope coefficient (aB1) of multivariable linear regression model for continuous outcome variables. Multivariable regression models are adjusted for baseline demographic characteristics (age, sex, ethnicity, race, BMI), medic al history (CAD, CHF, COPD, DM, HD, smoking status, decreased preoperative functional status), surgical history (prior aortic repair, CABG, CEA or CAS), medication history (Aspirin, P2Y12 inhibitors, ACE inhibitors, Betta blockers, Statis), Presentation, Urgency, Aortic Diameter, Preoperative creatinine, Preoperative hemoglobin, Anesthesia, ASA class,Number of stent-grafts64SOUTHERN CALIFORNIA VASCULAR SURGICAL SOCIETY'